Drugs: Safety
(asked on 14th November 2024) - View Source
Question to the Department for Science, Innovation & Technology:
What discussions he has had with the Medicines and Healthcare products Regulatory Agency on how to accelerate the acceptance of data generated in non-animal methods for drug safety decision making.
Answered by
Feryal Clark
Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
This question was answered on 20th November 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) attended a ministerial roundtable on accelerating the adoption of alternatives to using animals for drug development earlier this year.